OBJECTIVE: Recent studies have shown a role for Rac1 in regulating platelet functions, but how Rac1 is activated in platelets remains unclear. Phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchanger 1 (P-Rex1) was originally identified in neutrophils that regulates phagocyte functions. We sought to examine whether P-Rex1 plays a role in platelet activation. METHODS AND RESULTS: Western blotting showed P-Rex1 expression in mouse and human platelets. Mice lacking P-Rex1 exhibited prolonged bleeding time and increased rebleeding. When challenged with low doses of the G protein-coupled receptor (GPCR) agonists U46619 and thrombin, P-Rex1-/- platelets displayed significantly reduced secretion and aggregation compared with wild-type platelets. Increasing the concentration of these agonists could overcome the defect. Platelet aggregation induced by collagen, a non-GPCR agonist, was also compromised in the absence of P-Rex1. Along with these phenotypic changes were impaired Rac1 activation; reduced ATP secretion; and decreased phosphorylation of Akt, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase in P-Rex1-/- platelets on agonist stimulation. CONCLUSION: These results demonstrate for the first time the presence of P-Rex1 in platelets as well as its role in platelet secretion and aggregation induced by low-dose agonists for GPCR and by collagen.
OBJECTIVE: Recent studies have shown a role for Rac1 in regulating platelet functions, but how Rac1 is activated in platelets remains unclear. Phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchanger 1 (P-Rex1) was originally identified in neutrophils that regulates phagocyte functions. We sought to examine whether P-Rex1 plays a role in platelet activation. METHODS AND RESULTS: Western blotting showed P-Rex1 expression in mouse and human platelets. Mice lacking P-Rex1 exhibited prolonged bleeding time and increased rebleeding. When challenged with low doses of the G protein-coupled receptor (GPCR) agonists U46619 and thrombin, P-Rex1-/- platelets displayed significantly reduced secretion and aggregation compared with wild-type platelets. Increasing the concentration of these agonists could overcome the defect. Platelet aggregation induced by collagen, a non-GPCR agonist, was also compromised in the absence of P-Rex1. Along with these phenotypic changes were impaired Rac1 activation; reduced ATP secretion; and decreased phosphorylation of Akt, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase in P-Rex1-/- platelets on agonist stimulation. CONCLUSION: These results demonstrate for the first time the presence of P-Rex1 in platelets as well as its role in platelet secretion and aggregation induced by low-dose agonists for GPCR and by collagen.
Authors: Heidi C E Welch; W John Coadwell; Christian D Ellson; G John Ferguson; Simon R Andrews; Hediye Erdjument-Bromage; Paul Tempst; Phillip T Hawkins; Len R Stephens Journal: Cell Date: 2002-03-22 Impact factor: 41.582
Authors: Moon J Cho; Tamara I Pestina; Shirley A Steward; Clifford A Lowell; Carl W Jackson; T Kent Gartner Journal: Blood Date: 2002-04-01 Impact factor: 22.113
Authors: Muzaddid Sarker; Ardeshir Goliaei; Florence Golesi; Marjorie Poggi; Aaron A Cook; Mohammad A I Khan; Brenda R Temple; Lucia Stefanini; Matthias Canault; Wolfgang Bergmeier; Sharon L Campbell Journal: J Thromb Haemost Date: 2019-12-30 Impact factor: 5.824
Authors: Joseph E Aslan; Sandra M Baker; Cassandra P Loren; Kristina M Haley; Asako Itakura; Jiaqing Pang; Daniel L Greenberg; Larry L David; Ed Manser; Jonathan Chernoff; Owen J T McCarty Journal: Am J Physiol Cell Physiol Date: 2013-06-19 Impact factor: 4.249
Authors: Dingxin Pan; Richard T Amison; Yanira Riffo-Vasquez; Domenico Spina; Simon J Cleary; Michael J Wakelam; Clive P Page; Simon C Pitchford; Heidi C E Welch Journal: Blood Date: 2014-12-23 Impact factor: 22.113
Authors: Dingxin Pan; Mark A Barber; Kirsti Hornigold; Martin J Baker; Judit M Toth; David Oxley; Heidi C E Welch Journal: J Biol Chem Date: 2016-01-20 Impact factor: 5.157